Fiera Capital (Canada)’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.05M | Buy |
27,743
+10,531
| +61% | +$3.43M | 0.03% | 193 |
|
|
2025
Q1 | $4.65M | Buy |
17,212
+1,242
| +8% | +$335K | 0.02% | 231 |
|
|
2024
Q4 | $3.76M | Buy |
+15,970
| New | +$3.76M | 0.01% | 232 |
|
|
2021
Q2 | – | Sell |
-3,700
| Closed | -$522K | – | 574 |
|
|
2021
Q1 | $522K | Buy |
3,700
+185
| +5% | +$26.1K | ﹤0.01% | 473 |
|
|
2020
Q4 | $457K | Buy |
3,515
+800
| +29% | +$104K | ﹤0.01% | 536 |
|
|
2020
Q3 | $395K | Sell |
2,715
-340
| -11% | -$49.5K | ﹤0.01% | 497 |
|
|
2020
Q2 | $452K | Buy |
+3,055
| New | +$452K | ﹤0.01% | 490 |
|